Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity

Similar Items

• Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A
  od: Shi, Qizhen, i dr.
  Izdano: (2010)
• Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
  od: Shi, Qizhen, i dr.
  Izdano: (2006)
• The severe spontaneous bleeding phenotype in a novel hemophilia A rat model is rescued by platelet FVIII expression
  od: Shi, Qizhen, i dr.
  Izdano: (2020)
• The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunity
  od: Chen, Yingyu, i dr.
  Izdano: (2016)
• A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII
  od: Fahs, Scot A., i dr.
  Izdano: (2014)